TrialNature medicine2026

Intrathecal onasemnogene abeparvovec in treatment-naive patients with spinal muscular atrophy: a phase 3, randomized controlled trial.

Crystal M Proud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.